GSK plc
GSKPharmaceuticals
£18.14−0.96%As of Oct 29vs prior close
- Market cap
- $96.8B
- P/E (TTM)
- 12.7×
- P/E (FY1)
- 10.1×
- From 52W high
- −17.90%
- EPS (LTM)
- £1.18
- Revenue (LTM)
- £33.2B
- Net margin
- 17.50%
- Dividend yield
- 3.75%
Nomior Score
56
Steady ProfileTop 35% of the scored universe
Growth37
Quality59
Value61
Momentum56
Resilience59
Growth
+3.66%revenue a year over 3 fiscal years
YE22 £29.3BLTM £33.2B
Connections
Revenue to profitYE25
17% of revenue became net profit, up 9 pts on a year.